Renal Toll-like receptors: Recent advances and implications for disease

Nature Clinical Practice Nephrology

Volumn 2, Issue 10, 2006, Pages 568-581

  El Achkar, Tarek M ^a   Dagher, Pierre C ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Glomerulonephritis; Inflammation; Ischemia; Renal failure; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; CD14 ANTIGEN; CYTOKINE; LIGAND; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ACUTE KIDNEY FAILURE; ANTIGEN EXPRESSION; CLINICAL PRACTICE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG TARGETING; GLOMERULONEPHRITIS; HEART; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; INTESTINE; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY ISCHEMIA; LIVER; LUNG; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL RESEARCH; MOLECULAR DYNAMICS; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEINURIA; REVIEW; SCIENTIFIC LITERATURE; SEPSIS; SIGNAL TRANSDUCTION; UPREGULATION; URINARY TRACT INFECTION;

ANIMALS; GLOMERULONEPHRITIS; HUMANS; ISCHEMIA; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE; RENAL INSUFFICIENCY; SEPSIS; TOLL-LIKE RECEPTORS;

EID: 33749079461     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0300     Document Type: Review

References (150)

1. Beutler B and Rietschel ET (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169-176
2. Bradley SG (1981) Direct action of bacterial endotoxin on cells, mitochondria, and lysosomes. Prog Clin Biol Res 62: 3-14
3. Beutler B et al. (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552-554
4. Michie HR et al. (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104: 280-286
5. Tracey KJ et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474
6. Rothstein JL and Schreiber H (1988) Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA 85: 607-611
7. Medzhitov R et al. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397
8. Poltorak A et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088
9. Akira S and Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511
10. Akira S et al. (2006) Pathogen recognition and innate immunity. Cell 124: 783-801
11. Hoebe K et al. (2004) The interface between innate and adaptive immunity. Nat Immunol 5: 971-974
12. + T cell survival. J Immunol 172: 6065-6073
13. Pasare C and Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438: 364-368
14. Tsan MF and Gao B (2004) Endogenous ligands of Toll-like receptors. J Leukoc Biol 76: 514-519
15. Li M et al. (2001) An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 166: 7128-7135
16. Vabulas RM et al. (2002) HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 277: 15107-15112
17. Rifkin IR et al. (2005) Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204: 27-42
18. Oldfield V et al. (2005) Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol 6: 195-200
19. Chakravarty S and Herkenham M (2005) Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci 25: 1788-1796
20. Basu S and Fenton MJ (2004) Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 286: L887-L892
21. Baumgarten G et al. (2001) In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis 183: 1617-1624
22. Matsumura T et al. (2000) Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 20: 915-921
23. Leemans JC et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903
24. Wolfs TG et al. (2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation. J Immunol 168: 1286-1293
25. Cunningham PN et al. (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172: 2629-2635
26. Palmer SM et al. (2006) Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 20: 30-36
27. Chowdhury P et al. (2004) Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int 66: 1334-1344
28. Anders HJ et al. (2004) Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15: 854-867
29. Bell JK et al. (2003) Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol 24: 528-533
30. Burns K et al. (1998) MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273: 12203-12209
31. Muzio M et al. (1997) IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612-1615
32. Karin M and Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18: 621-663
33. Platanias LC (2003) Map kinase signaling pathways and hematologic malignancies. Blood 101: 4667-4679
34. Schieven GL (2005) The biology of p38 kinase: a central role in inflammation. Curr Top Med Chem 5: 921-928
35. Zhang W and Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12: 9-18
36. Ninomiya-Tsuji J et al. (1999) The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256
37. Akira S (2003) Toll-like receptor signaling. J Biol Chem 278: 38105-38108
38. Akira S and Hoshino K (2003) Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling. J Infect Dis 187 (Suppl 2): S356-S363
39. Bussolati B et al. (2002) Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. Int J Mol Med 10: 441-449
40. Ortiz-Arduan A et al. (1996) Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 271: F1193-F1201
41. Peherstorfer E et al. (2002) Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. Am J Physiol Renal Physiol 283: F190-F196
42. Oberholzer C et al. (2001) Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 15: 879-892
43. Guo R et al. (2004) Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 15: 3093-3102
44. Bannerman DD et al. (2002) The Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β. J Clin Invest 109: 419-425
45. Duckett CS (2002) Apoptosis and NF-κB: the FADD connection. J Clin Invest 109: 579-580
46. Aliprantis AO et al. (1999) Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739
47. Aliprantis AO et al. (2000) The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J 19: 3325-3336
48. Kaiser WJ and Offermann MK (2005) Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 174: 4942-4952
49. Cunningham PN et al. (2002) Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168: 5817-5823
50. Peralta Soler A et al. (1996) Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am J Physiol 270: F869-F879
51. Zarember KA and Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168: 554-561
52. Nishimura M and Naito S (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28: 886-892
53. Backhed F et al. (2001) Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol 3: 153-158
54. Tsuboi N et al. (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169: 2026-2033
55. Patole PS et al. (2005) Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 16: 1326-1338
56. Wornle M et al. (2006) Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168: 370-385
57. Anders HJ et al. (2003) Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol 14: 317-326
58. Anders HJ et al. (2004) Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 18: 534-536
59. Pawar RD et al. (2006) Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol 17: 141-149
60. Zhang D et al. (2004) A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526
61. Kim BS et al. (2005) Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 79: 1370-1377
62. Lim SW et al. (2005) Cyclosporine-induced renal injury induces toll-like receptor and maturation of dendritic cells. Transplantation 80: 691-699
63. Samuelsson P et al. (2004) Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 72: 3179-3186
64. Laestadius A et al. (2003) Developmental aspects of Escherichia coli-induced innate responses in rat renal epithelial cells. Pediatr Res 54: 536-541
65. El-Achkar TM et al. (2006) Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol 290: F1034-F1043
66. Riedemann NC et al. (2003) The enigma of sepsis. J Clin Invest 112: 460-467
67. Hotchkiss RS and Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150
68. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420: 885-891
69. Watson J and Riblet R (1974) Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J Exp Med 140: 1147-1161
70. Sultzer BM (1968) Genetic control of leucocyte responses to endotoxin. Nature 219: 1253-1254
71. Apte RN et al. (1977) Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide. J Immunol 119: 1898-1902
72. Woods JP et al. (1988) Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect Immun 56: 1950-1955
73. O'Brien AD et al. (1980) Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol 124: 20-24
74. Schrier RW and Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351: 159-169
75. Wan L et al. (2003) The pathogenesis of septic acute renal failure. Curr Opin Crit Care 9: 496-502
76. Knotek M et al. (2001) Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59: 2243-2249
77. Eskandari MK et al. (1992) Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148: 2724-2730
78. Bertani T et al. (1989) Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 134: 419-430
79. Zager RA et al. (2005) Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-α generation and systemic release. Am J Physiol Renal Physiol 289: F289-F297
80. Lehnardt S et al. (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 100: 8514-8519
81. Fearns C et al. (1995) Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 181: 857-866
82. Morrissey J et al. (2000) Induction of CD14 in tubular epithelial cells during kidney disease. J Am Soc Nephrol 11: 1681-1690
83. Pugin J et al. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 90: 2744-2748
84. Fearns C and Loskutoff DJ (1997) Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun 65: 4822-4831
85. Dunzendorfer S et al. (2004) TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol 173: 1166-1170
86. Zhai Y et al. (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173: 7115-7119
87. Shen XD et al. (2005) Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 5: 1793-1800
88. Chong AJ et al. (2004) Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128: 170-179
89. Shishido T et al. (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108: 2905-2910
90. Ohashi K et al. (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the tolllike receptor-4 complex. J Immunol 164: 558-561
91. Alexopoulou L et al. (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413: 732-738
92. Shahin RD et al. (1987) Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol 138: 3475-3480
93. Haraoka M et al. (1999) Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis 180: 1220-1229
94. Svanborg C et al. (2001) Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J Infect Dis 183 (Suppl 1): S61-S65
95. Schilling JD et al. (2003) Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci USA 100: 4203-4208
96. Patole PS et al. (2005) Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 68: 2582-2587
97. Hedlund M et al. (2001) Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol Microbiol 39: 542-552
98. Frendeus B et al. (2001) Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 40: 37-51
99. Schilling JD et al. (2003) CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun 71: 1470-1480
100. Backhed F et al. (2002) TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell Microbiol 4: 493-501
101. Serafini-Cessi F et al. (2003) Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42: 658-676
102. Orskov I et al. (1980) Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet 1: 887
103. Parkkinen J et al. (1988) Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins. Infect Immun 56: 2623-2630
104. Pak J et al. (2001) Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 276: 9924-9930
105. Bates JM et al. (2004) Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65: 791-797
106. Saemann MD et al. (2005) Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 115: 468-475
107. Pockley AG (2001) Heat shock proteins, anti-heat shock protein reactivity and allograft rejection. Transplantation 71: 1503-1507
108. Goldstein DR et al. (2003) Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 111: 1571-1578
109. McLaughlin K et al. (2002) Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. Transplantation 74: 813-816
110. Tesar BM et al. (2004) TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein. Am J Transplant 4: 1429-1439
111. Arbour NC et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191
112. Ducloux D et al. (2005) Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 67: 2454-2461
113. Pavenstadt H et al. (2003) Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307
114. Reiser J et al. (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113: 1390-1397
115. Hoebe K et al. (2003) Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 4: 1223-1229
116. Schmidtke JR and Johnson AG (1971) Regulation of the immune system by synthetic polynucleotides. I. Characteristics of adjuvant action on antibody synthesis. J Immunol 106: 1191-1200
117. Condie RM et al. (1955) Effect of meningococcal endotoxin on the immune response. Proc Soc Exp Biol Med 90: 355-360
118. Leadbetter EA et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Tolllike receptors. Nature 416: 603-607
119. Christensen SR et al. (2005) Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202: 321-331
120. Hemmi H et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745
121. Means TK et al. (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115: 407-417
122. Ronnblom L and Alm GV (2001) A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 194: F59-F63
123. Wu X and Peng SL (2006) Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 54: 336-342
124. Boule MW et al. (2004) Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199: 1631-1640
125. Hur JW et al. (2005) Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens 65: 266-270
126. Sanchez E et al. (2004) Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 63: 54-57
127. Patole PS et al. (2005) G-rich DNA suppresses systemic lupus. J Am Soc Nephrol 16: 3273-3280
128. Heil F et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529
129. Will CL and Luhrmann R (2001) Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol 13: 290-301
130. Hawn TR et al. (2005) A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci USA 102: 10593-10597
131. Klinman DM (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4: 249-258
132. Ulevitch RJ (2004) Therapeutics targeting the innate immune system. Nat Rev Immunol 4: 512-520
133. Schmidt C (2006) Toll-like receptor therapies compete to reduce side effects. Nat Biotechnol 24: 230-231
134. Rossignol DP and Lynn M (2005) TLR4 antagonists for endotoxemia and beyond. Curr Opin Investig Drugs 6: 496-502
135. Takeuchi O et al. (2002) Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10-14
136. Hoshino K et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752
137. Schwandner R et al. (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274: 17406-17409
138. Underhill DM et al. (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815
139. Bulut Y et al. (2002) Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 168: 1435-1440
140. Kawasaki K et al. (2000) Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 275: 2251-2254
141. Okamura Y et al. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276: 10229-10233
142. Termeer C et al. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99-111
143. Smiley ST et al. (2001) Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167: 2887-2894
144. Johnson GB et al. (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168: 5233-5239
145. Hayashi F et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103
146. Ozinsky A et al. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97: 13766-13771
147. Takeuchi O et al. (2001) Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13: 933-940
148. Hemmi H et al. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3: 196-200
149. Jurk M et al. (2002) Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3: 499
150. Yarovinsky F et al. (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629